Funded Startups in Glasgow
Disclosed round sizes in Glasgow cluster mostly in the hundreds of thousands to single-digit millions, but one entry stands apart: BLK’s $63M round on 2025…
Disclosed round sizes in Glasgow cluster mostly in the hundreds of thousands to single-digit millions, but one entry stands apart: BLK’s $63M round on 2025-02-27. Aside from BLK, the next-largest disclosed amounts include Sulmara’s $19M (2024-11-28) and ENOUGH’s $44M (2023-08-21), while several others sit far lower (for example, Profylr at $60K on 2025-02-20). The 50 rows shown span 2021-03-04 (Adimo) through 2025-11-30 (Sentinel), with multiple entries concentrated in late 2024 and mid-2025 rather than evenly distributed. Sector-wise, “Biotechnology” appears in at least four entries (Keltic Pharma Therapeutics in 2024-12-17 at $440K; ENOUGH in both 2024-02-15 and 2023-08-21; Solasta Bio in 2023-04-11; plus Aurum Biosciences at $930K on 2024-01-24). The listing also shows heavy classification ambiguity: “Series Unknown” appears 20 times, and “undisclosed” amounts appear in at least 10 rows, including Clyde Hydrogen Systems (2025-09-09) and Murphy Wealth (2025-04-16).
Most recent rounds
50 shownRelated listings
Frequently asked
What stands out in disclosed round size for Glasgow, and how extreme is the gap?
BLK’s disclosed $63M round on 2025-02-27 is the largest disclosed amount in the dataset and is far above most other disclosed rounds. The next-largest disclosed amounts are ENOUGH at $44M on 2023-08-21 and Sulmara at $19M on 2024-11-28, indicating a clear top-end outlier rather than a gradual spread.
Do the rounds cluster in a particular date window within the 2021–2025 range shown?
Rounds are not uniform across the period: several entries land in mid-2024 (e.g., Vector Photonics $2M on 2024-06-07; Aurum Biosciences $930K on 2024-01-24) and again in early-to-mid 2025 (e.g., Neuranics $8M on 2025-04-09; Sentinel $2M on 2025-11-30 is the most recent). The newest row is 2025-11-30 (Sentinel), while the oldest is 2021-03-04 (Adimo).
Which sectors appear most consistently across this Glasgow list?
Biotechnology is the clearest repeat: Keltic Pharma Therapeutics ($440K on 2024-12-17), Aurum Biosciences ($930K on 2024-01-24), Solasta Bio (undisclosed on 2023-04-11), and ENOUGH (undisclosed on 2024-02-15 and $44M on 2023-08-21). Hardware also shows up repeatedly (e.g., Neuranics $8M on 2025-04-09; Vector Photonics $2M on 2024-06-07; Krucial at $4M on 2023-09-12).
How much of the list uses ambiguous stage or missing disclosed amounts?
Stage labeling is frequently unspecified: “Series Unknown” appears in 20 of the 50 rows, and “undisclosed” amounts appear in at least 10 rows (including encompass on 2025-09-29 and Clyde Hydrogen Systems on 2025-09-09). This matters when comparing size outliers, because several high-importance categories (like energy) show undisclosed figures rather than comparable dollar amounts.
Is there a low-end outlier that differs from the rest of the disclosed amounts?
Profylr at $60K on 2025-02-20 is the smallest disclosed amount among rows with disclosed figures, placing it below the more typical “hundreds of thousands to a few millions” range. Several other early-2025 entries remain in the low millions (e.g., Microplate Dx $640K on 2025-09-09; POTR $670K on 2025-05-20), underscoring how low $60K is relative to the dataset’s disclosed floor beyond any undisclosed rows.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.